Todays PR Biomarkers
So how will the Biomarkers help AVXL with their study? They do a study, then see which patients had the best results and what Biomarkers or can they skip this part ? ....then they can screen a population of AD patients and get an indication for AD patients with certain Biomarkers? So That sounds like at least another 1 or 2 trials? That could take another year at least if not longer.
ANAVEX®2-73 Programs Update:
The Company has completed both RNA and whole exome DNA genome sequencing from ANAVEX®2-73-treated patients utilizing Illumina HiSeq 2500 Next Generation Sequencing (NGS) technology. The analysis of this data has characterized several genomic alterations in well-characterized targets that have the potential to be used as biomarkers, which the Company plans to use to identify optimal patients in forthcoming clinical trials.